ApoB gene-silencing oligonucleotides (Idera Pharmaceuticals)

N/A

Report date: 2025/03/14 18:14:23
NME

Base Information

Drug NameApoB gene-silencing oligonucleotides (Idera Pharmaceuticals)
Drug Alias Nameapolipoprotein B gene-silencing oligonucleotides (Idera Pharmaceuticals)ApoB targeting GSOs (Idera Pharmaceuticals)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionApolipoprotein B-100 inhibitors
TargetsApolipoprotein B-100
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAceragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAceragen Inc
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A